ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer.

Carsten Denkert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.